최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기The Lancet. Infectious diseases, v.10 no.9, 2010년, pp.643 - 651
Lehmann, Helmar C (Department of Neurology, Heinrich-Heine-University, Dü) , Hartung, Hans-Peter (sseldorf, Germany) , Kieseier, Bernd C (Department of Neurology, Heinrich-Heine-University, Dü) , Hughes, Richard AC (sseldorf, Germany)
Summary Guillain-Barré syndrome (GBS) is an acute, acquired, monophasic autoimmune disorder of peripheral nerves that develops in susceptible individuals after infection and, in rare cases, after immunisation. Exposure to influenza via infection or vaccination has been associated with G...
Lancet Black 374 2115 2009 10.1016/S0140-6736(09)61877-8 Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines
J Infect Dis Evans 200 321 2009 10.1086/603560 “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events
Lancet Nicholson 362 1733 2003 10.1016/S0140-6736(03)14854-4 Influenza
N Engl J Med Dawood 360 2605 2009 10.1056/NEJMoa0903810 Emergence of a novel swine-origin influenza A (H1N1) virus in humans
Am J Epidemiol Schonberger 110 105 1979 10.1093/oxfordjournals.aje.a112795 Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977
Expert Rev Vaccines Iskander 7 75 2008 10.1586/14760584.7.1.75 Monitoring the safety of annual and pandemic influenza vaccines: lessons from the US experience
Am J Epidemiol Stowe 169 382 2009 10.1093/aje/kwn310 Investigation of the temporal association of Guillain-Barré syndrome with influenza vaccine and influenzalike illness using the United Kingdom General Practice Research Database
PLoS One Tam 2 e344 2007 10.1371/journal.pone.0000344 Guillain-Barré syndrome and preceding infection with campylobacter, influenza and Epstein-Barr virus in the general practice research database
Lancet Neurol van Doorn 7 939 2008 10.1016/S1474-4422(08)70215-1 Clinical features, pathogenesis, and treatment of Guillain-Barré syndrome
Lancet Hughes 366 1653 2005 10.1016/S0140-6736(05)67665-9 Guillain-Barré syndrome
Curr Opin Neurol Hartung 15 571 2002 10.1097/00019052-200210000-00008 Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome
Brain Ho 118 597 1995 10.1093/brain/118.3.597 Guillain-Barré syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
Curr Opin Immunol Yuki 17 577 2005 10.1016/j.coi.2005.09.004 Carbohydrate mimicry: a new paradigm of autoimmune diseases
Ann Neurol Halstead 58 203 2005 10.1002/ana.20546 Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome
Curr Opin Neurol Overell 18 562 2005 10.1097/01.wco.0000173284.25581.2f Recent developments in Miller Fisher syndrome and related disorders
J Peripher Nerv Syst Willison 10 94 2005 10.1111/j.1085-9489.2005.0010202.x The immunobiology of Guillain-Barré syndromes
J Neurol Neurosurg Psychiatry O'Leary 61 649 1996 10.1136/jnnp.61.6.649 Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides
J Neurol Neurosurg Psychiatry Rees 64 74 1998 10.1136/jnnp.64.1.74 Epidemiological study of Guillain-Barré syndrome in south east England
J Infect Dis Hughes 176 suppl 2 S92 1997 10.1086/513793 Clinical and epidemiologic features of Guillain-Barré syndrome
Curr Opin Neurol Govoni 14 605 2001 10.1097/00019052-200110000-00009 Epidemiology of the Guillain-Barré syndrome
Eur J Neurol Cheng 7 11 2000 10.1046/j.1468-1331.2000.00006.x Incidence of Guillain-Barré syndrome in Sweden 1996
Acta Neurol Scand Sedano 89 287 1994 10.1111/j.1600-0404.1994.tb01682.x Guillain-Barré syndrome in Cantabria, Spain. An epidemiological and clinical study
J Peripher Nerv Syst Lehmann 12 285 2007 10.1111/j.1529-8027.2007.00150.x Incidence of Guillain-Barré syndrome in Germany
N Engl J Med Rees 333 1374 1995 10.1056/NEJM199511233332102 Campylobacter jejuni infection and Guillain-Barré syndrome
Neurology Jacobs 51 1110 1998 10.1212/WNL.51.4.1110 The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study
Muscle Nerve Kieseier 30 131 2004 10.1002/mus.20076 Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system
Nat Clin Pract Neurol zu Horste 3 198 2007 10.1038/ncpneuro0452 From bench to bedside-experimental rationale for immune-specific therapies in the inflamed peripheral nerve
Lancet Infect Dis Yuki 1 29 2001 10.1016/S1473-3099(01)00019-6 Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes
Brain Griffin 118 577 1995 10.1093/brain/118.3.577 Guillain-Barré syndrome in northern China. The spectrum of neuropathological changes in clinically defined cases
Medicine Asbury 4 173 1969 10.1097/00005792-196905000-00001 The inflammatory lesion in idiopathic polyneuritis
Ann Neurol Hall 31 441 1992 10.1002/ana.410310416 Motor nerve biopsy in severe Guillain-Barré syndrome
Neurology Massaro 51 394 1998 10.1212/WNL.51.2.394 Nerve biopsy in children with severe Guillain-Barré syndrome and inexcitable motor nerves
Ann Neurol Hafer-Macko 40 635 1996 10.1002/ana.410400414 Acute motor axonal neuropathy: an antibody-mediated attack on axolemma
Muscle Nerve Hartung 18 137 1995 10.1002/mus.880180202 Immunopathogenesis and treatment of the Guillain-Barré syndrome-Part I
J Neuroimmunol Hughes 100 74 1999 10.1016/S0165-5728(99)00195-2 Pathogenesis of Guillain-Barré syndrome
Ann Neurol Ho 45 168 1999 10.1002/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6 Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome
Neurology Yuki 40 1900 1990 10.1212/WNL.40.12.1900 Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis
Muscle Nerve Yuki 15 899 1992 10.1002/mus.880150806 Severe acute axonal form of Guillain-Barré syndrome associated with IgG anti-GD1a antibodies
Muscle Nerve Yuki 16 642 1993 10.1002/mus.880160610 Association of IgG anti-GD1a antibody with severe Guillain-Barré syndrome
J Neurol Neurosurg Psychiatry Willison 56 20406 1993 10.1136/jnnp.56.2.204 Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside
J Neuroimmunol Lopez 128 69 2002 10.1016/S0165-5728(02)00139-X High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs. disease-associated antibodies
Brain Lopez 131 1926 2008 10.1093/brain/awn074 Structural requirements of anti-GD1a antibodies determine their target specificity
J Neurosci Lehmann 27 27 2007 10.1523/JNEUROSCI.4017-06.2007 Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model
Ann Neurol Sheikh 56 228 2004 10.1002/ana.20173 An anti-ganglioside antibody-secreting hybridoma induces neuropathy in mice
J Neurosci Goodfellow 25 1620 2005 10.1523/JNEUROSCI.4279-04.2005 Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy
J Neurosci Susuki 27 3956 2007 10.1523/JNEUROSCI.4401-06.2007 Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers
Ann Neurol Yuki 49 712 2001 10.1002/ana.1012 Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside
Proc Natl Acad Sci USA Yuki 101 11404 2004 10.1073/pnas.0402391101 Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome
Muscle Nerve Arasaki 16 587 1993 10.1002/mus.880160603 Acute conduction block in vitro following exposure to antiganglioside sera
J Neurol Sci Arasaki 161 163 1998 10.1016/S0022-510X(98)00283-4 The pattern of antiganglioside antibody reactivities producing myelinated nerve conduction block in vitro
Neurosci Lett Buchwald 201 163 1995 10.1016/0304-3940(95)12155-2 Immunoglobulin G from a patient with Miller-Fisher syndrome rapidly and reversibly depresses evoked quantal release at the neuromuscular junction of mice
Ann Neurol Buchwald 44 913 1998 10.1002/ana.410440610 Neuromuscular blockade by IgG antibodies from patients with Guillain-Barré syndrome: a macro-patch-clamp study
Eur J Neurosci Buchwald 10 281 1998 10.1046/j.1460-9568.1998.00053.x Pre- and postsynaptic blockade of neuromuscular transmission by Miller-Fisher syndrome IgG at mouse motor nerve terminals
Brain Halstead 127 2109 2004 10.1093/brain/awh231 Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy
Ann Neurol Yuki 36 791 1994 10.1002/ana.410360517 Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome
Eur J Biochem Aspinall 213 1017 1993 10.1111/j.1432-1033.1993.tb17849.x Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4, O:23, and O:36 lipopolysaccharides
Infect Immun Aspinall 62 2122 1994 10.1128/IAI.62.5.2122-2125.1994 Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure
Infect Immun Neisser 65 4038 1997 10.1128/IAI.65.10.4038-4042.1997 Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome
Glycoconj J Hidari 24 583 2007 10.1007/s10719-007-9055-y Binding kinetics of influenza viruses to sialic acid-containing carbohydrates
N Engl J Med Moscona 353 1363 2005 10.1056/NEJMra050740 Neuraminidase inhibitors for influenza
Proc Am Philos Soc Taubenberger 150 86 2006 The origin and virulence of the 1918 “Spanish” influenza virus
Bull Hist Med Patterson 65 4 1991 The geography and mortality of the 1918 influenza pandemic
N Engl J Med Morens 361 225 2009 10.1056/NEJMp0904819 The persistent legacy of the 1918 influenza virus
Proc Natl Acad Sci USA Geiss 99 10736 2002 10.1073/pnas.112338099 Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza
Bull Mem Soc Med Hop Paris Guillain 40 1462 1916 Sur un syndrome de radiculonévrite avec hyperalbuminose du liquide céphalo-rachidien sans réaction cellulaire. Remarques sur les caractères cliniques et graphiques des réflexes tendineux
Rev Neurol (Paris) Draganescu 2 517 1927 Sur un cas de radiculu-névrite curable (syndrome de Guillain-Barré) apparue au cours d'une ostéomyélite du bras
Can Med Assoc J Howland 9 727 1919 The nervous conditions associated with influenza
Proc R Soc Med Walshe 13 7 1920 Forms of peripheral neuritis among troops serving with the Egyptian expeditionary force, 1915-19
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr Marcus 54 166 1920 10.1007/BF02866117 Die Influenza und das Nervensystem. Studie während der Epidemie in Schweden 1918-1919
Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr Wexberg 49 14 1919 10.1007/BF02901107 Erkrankungen der peripheren Nerven im Kriege
Eur Arch Psychiatry Clin Neurosci Sett 3 563 1920 Zur Ätiologie und Symptomatologie der Polyneuritis
Ir J Med Sci Keelan 438 272 1962 10.1007/BF02957017 Post-influenzal peripheral neuritis
AMA Arch Neurol Psychiatry Wells 81 699 1959 10.1001/archneurpsyc.1959.02340180033005 Guillain-Barré syndrome and virus of influenza A (Asian strain); report of two fatal cases during the 1957 epidemic in Wales
Clin Infect Dis Sivadon-Tardy 48 48 2009 10.1086/594124 Guillain-Barré syndrome and influenza virus infection
Emerg Infect Dis Sivadon-Tardy 12 990 2006 10.3201/eid1206.051369 Guillain-Barré syndrome, greater Paris area
Emerg Infect Dis Tam 12 1880 2006 10.3201/eid1212.051032 Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barré syndrome, England
Arch Intern Med Zambon 161 2116 2001 10.1001/archinte.161.17.2116 Diagnosis of influenza in the community: relationship of clinical diagnosis to confirmed virological, serologic, or molecular detection of influenza
N Engl J Med Falsey 352 1749 2005 10.1056/NEJMoa043951 Respiratory syncytial virus infection in elderly and high-risk adults
Intensive Care Med Chaari 36 1275 2010 10.1007/s00134-010-1895-4 Guillain-Barré syndrome related to pandemic influenza A (H1N1) infection
Neurocrit Care Kutleša 13 98 2010 10.1007/s12028-010-9365-y Acute motor axonal neuropathy associated with pandemic H1N1 influenza A infection
Minerva Med Mule 47 450 1956 Two cases of polyradiculoneuritis caused by influenza virus B [Italian]
Presse Med Bertrand 79 2328 1971 Guillain-Barré polyradiculoneuritis and influenza virus [French]
Cesk Neurol Neurochir Novák 38 314 1975 Guillain-Barré syndrome as a sequela of influenza [Czech]
Ann Neurol Enders 34 136 1993 10.1002/ana.410340208 The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders
Neurochem Res Adelmann 17 887 1992 10.1007/BF00993264 Molecular mimicry and the autoimmune response to the peripheral nerve myelin P0 glycoprotein
J Infect Dis Nachamkin 198 226 2008 10.1086/589624 Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome
Eur J Neurol Simpson 16 e81 2009 10.1111/j.1468-1331.2009.02569.x Sensori-motor Guillain-Barré syndrome with anti-GD1b antibodies following influenza A infection
Emerg Infect Dis Sencer 12 29 2006 10.3201/eid1201.051007 Reflections on the 1976 swine flu vaccination program
JAMA Haber 292 2478 2004 10.1001/jama.292.20.2478 Guillain-Barré syndrome following influenza vaccination
Am J Epidemiol Safranek 133 940 1991 10.1093/oxfordjournals.aje.a115973 Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group
JAMA Marks 243 2490 1980 10.1001/jama.1980.03300500016019 Guillain-Barré syndrome in recipients of A/New Jersey influenza vaccine
JAMA Kaplan 248 698 1982 10.1001/jama.1982.03330060038030 Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination
N Engl J Med Hurwitz 304 1557 1981 10.1056/NEJM198106253042601 Guillain-Barré syndrome and the 1978-1979 influenza vaccine
Vaccine Vellozzi 27 2114 2009 10.1016/j.vaccine.2009.01.125 Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring
Arch Intern Med Hughes 166 1301 2006 10.1001/archinte.166.12.1301 No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000
Arch Intern Med Juurlink 166 2217 2006 10.1001/archinte.166.20.2217 Guillain-Barré syndrome after influenza vaccination in adults: a population-based study
Am J Epidemiol Roscelli 133 952 1991 10.1093/oxfordjournals.aje.a115974 Guillain-Barré syndrome and influenza vaccination in the US Army, 1980-1988
N Engl J Med Lasky 339 1797 1998 10.1056/NEJM199812173392501 The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines
Ann Neurol McFarlin 27 suppl S25 1990 10.1002/ana.410270708 Immunological parameters in Guillain-Barré syndrome
J Peripher Nerv Syst Kuitwaard 14 310 2009 10.1111/j.1529-8027.2009.00243.x Recurrences, vaccinations and long-term symptoms in GBS and CIDP
J Neurol Neurosurg Psychiatry Kuitwaard 80 56 2009 10.1136/jnnp.2008.156463 Recurrent Guillain-Barré syndrome
Neurology Seyal 28 725 1978 10.1212/WNL.28.7.725 Recurrent Guillain-Barré syndrome following influenza vaccine
J Neurol Neurosurg Psychiatry Pritchard 73 348 2002 10.1136/jnnp.73.3.348 Risk of relapse of Guillain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunisation
Neurology Wijdicks 55 452 2000 10.1212/WNL.55.3.452 Influenza vaccine and the risk of relapse of Guillain-Barré syndrome
Arch Soc Esp Oftalmol Blanco-Marchite 83 433 2008 10.4321/S0365-66912008000700008 Miller Fisher syndrome, internal and external ophthalmoplegia after flu vaccination [Spanish]
Liver Transpl Moon 12 1537 2006 10.1002/lt.20864 Guillain-Barré syndrome triggered by influenza vaccination in a recipient of liver transplant on FK506
Muscle Nerve Aggarwal 18 1199 1995 10.1002/mus.880181017 A reversible paralytic syndrome with anti-GD1b antibodies following influenza immunization
Infect Immun Bowes 70 5008 2002 10.1128/IAI.70.9.5008-5018.2002 Tolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome
Infect Immun Kendal 29 966 1980 10.1128/iai.29.3.966-971.1980 Further studies of the neuraminidase content of inactivated influenza vaccines and the neuraminidase antibody responses after vaccination of immunologically primed and unprimed populations
Vaccine Wood 21 1786 2003 10.1016/S0264-410X(03)00073-2 The influenza vaccine licensing process
Aleccia
Plater
MMWR Morb Mortal Wkly Rep 59 657 2010 Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine-United States, 2009-2010
※ AI-Helper는 부적절한 답변을 할 수 있습니다.